- Price is above the Trend Line, keeping the weekly tape constructive.
- Activity pressure is positive on the latest completed week.
- Latest weekly return ranks in the strongest part of its sector group.
BDX
VIE
Week ended 07 Aug 2026
Weekly Investor Report
Becton, Dickinson and Company · Healthcare · Medical Instruments & Supplies
Latest close
152.1 EUR
6.9%
latest week
Weekly setup
Mixed setup
The weekly trend is not active. Price is 9.6% above the Trend Line and sits at 54.4% of its 52-week range. The latest completed week returned 6.9%, after a 14.3% four-week move. The latest news-sentiment score is 54/100.
Setup score
37
out of 100
Latest Close
152.1 EUR
7 Aug 2026
1W Return
6.9%
latest completed week
4W Return
14.3%
short-term follow-through
12W Return
24.6%
quarterly tape
Trend Breadth
25.0%
13 of 52 weeks active
Volume Ratio
-
vs 13-week average
- The trend backdrop is inactive, so price action has not confirmed a constructive regime.
- Price is below Fair Value, so the market is still discounting the latest tape.
- Next-week expectancy is negative at 42.68% based on similar historical setup states.
- Activity pressure is weak, so confirmation is not yet broad enough.
- Trend Line remains the key weekly regime level.
- Activity pressure is the gauge to monitor for confirmation or fade.
Price follow-through
6.9%
Latest completed week; four-week move 14.3%.
Indicator stack
14/80
Trend and activity pressure are weighted against the latest 12-week confirmation window.
Trend backdrop
Active
The trend backdrop defines the current weekly regime.
Patient Capital
Quiet
Activity-pressure buy-signal status for institutional accumulation timing.
Next-Week Expectancy
Negative 42.68%
Historical one-week expectancy contributes to the evidence score when direction is confirmed.
News sentiment
54/100
17 relevant articles in the latest sentiment read.
01 · Price action
Study the full chart
Where price is—and whether the trend supports it
The weekly trend is not active. Price is 9.6% above the Trend Line and sits at 54.4% of its 52-week range. The latest completed week returned 6.9%, after a 14.3% four-week move.
52-week price path
Price vs Trend Line and Fair Value
Price
Trend Line
Fair Value
02 · Volume and demand
Is real participation confirming the move?
Latest weekly volume is - the 13-week average. Participation data is incomplete.
26-week volume confirmation
Bar height shows volume; colour shows the weekly price direction
13 Feb
20 Feb
27 Feb
6 Mar
13 Mar
20 Mar
27 Mar
3 Apr
10 Apr
17 Apr
24 Apr
1 May
8 May
15 May
22 May
29 May
5 Jun
12 Jun
19 Jun
26 Jun
3 Jul
10 Jul
17 Jul
24 Jul
31 Jul
7 Aug
Up week
Down week
Demand beneath price
Activity pressure and institutional-style signals
These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.
Activity pressure path
Latest 0.1812-week average 0.06
12-week confirmation
Trend active0/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure6/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership0/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.18Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers
No recent accumulation markers. No reversal markers.
03 · Momentum and leadership
Is performance persistent—and is the stock leading?
Performance is 14.3% over four weeks, 24.6% over 12 weeks, and -5.7% over one year. The current trend has remained active for 0 consecutive weeks.
Performance by holding period
Active trend streak0 weeks
Active weeks in one year13
Trend breadth25.0%
Activity pressure vs relative leadership
Activity pressureRelative leadership
Pressure1.14Latest activity-pressure read.
Pressure change117.6%Four-week change in activity pressure.
Leadership-17.45Latest relative-leadership reading.
RS change38.3%Four-week change in relative leadership.
04 · Fundamentals and valuation
Open full factor analysis
What investors are paying for—and the quality behind it
A published fundamentals and factor snapshot is not available for this company.
No published fundamental snapshot is available for this company.
05 · Ownership, options, and sentiment
What other market participants are doing
Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.
Insider activity-
No recent insider transactions are stored for this company.
News sentiment54/100
Weighted news tone is neutral across 17 relevant articles.
5 positive · 12 neutral · 0 negativePatient CapitalQuiet
Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal
06 · Catalysts and risk
What can move the shares—and how volatile the path has been
Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.
Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-14.8%Distance below the 52-week high.
13-week volatility3.8%Standard deviation of weekly returns.
Weekly gains and losses
Latest 26 completed weeksEach bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.
13 Feb
13 Mar
10 Apr
8 May
5 Jun
3 Jul
7 Aug
Weeks higher13 of 2612 weeks finished lower.
Best week+15.7%Week of 13 Feb.
Worst week-4.2%Week of 27 Feb.
Latest week+6.9%Week of 7 Aug.
Shape of recent returns
Strong gains6
Modest gains7
Flat weeks1
Modest losses10
Sharp losses2
Recent vol3.8%13-week weekly-return volatility.
Base vol5.1%52-week weekly-return volatility.
Up/down split23/28Count of positive and negative weeks in the 52-week window.
Average skew3.7% / -3.0%Average positive week versus average negative week.
07 · Sector and peer context
Is this stock leading—or simply moving with its group?
Sector and industry breadth distinguish company-specific strength from a broad group move.
SectorAT Healthcare
4-week rank8 / 100
Group average2.6%
Trend breadth47.0%
Trend47.0%active weekly trend signals
MD73.0%positive activity pressure
RS10.0%positive relative leadership
Four-week leaders
IndustryAT Medical Instruments & Supplies
4-week rank4 / 18
Group average3.2%
Trend breadth33.3%
Trend33.3%active weekly trend signals
MD83.3%positive activity pressure
RS11.1%positive relative leadership
Four-week leaders
08 · Evidence and weekly data
The underlying research record
Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.
Weekly tape28/100
Trend, activity pressure, participation, and risk combine to a 28/100 tape read.
Indicator analysis22/100Latest 12-week confirmation: trend 0/12, activity pressure 6/12, relative leadership 0/12.
Activity pressure 0.18; No reversal markers Next-Week ExpectancyNegative 42.68%Next-week expectancy is negative with a 42.68% historical one-week setup read.
Adds short-term historical context without overriding trend, activity, or relative leadership. Factors50/100No published factor snapshot is available yet.
Patient CapitalQuietActivity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal Sentiment54/100Weighted news tone is neutral across 17 relevant articles.
Becton Dickinson & Co (BDX) Stock Up 3.8% and Still Undervalued -- GF Score: 76/100 Insiders50/100No recent insider transaction evidence is stored.
Earnings50/100No stored earnings event is currently attached to this ticker.
| Week | Close | Return | Trend Line | Fair Value | Pressure | Leadership | Volume | Trend |
|---|---|---|---|---|---|---|---|---|
| 7 Aug 2026 | 152.1 EUR | 6.9% | 138.8 EUR | 184.1 EUR | 1.14 | -17.45 | 0 | Off |
| 31 Jul 2026 | 142.3 EUR | 3.8% | 139.5 EUR | 184.7 EUR | 1.10 | -21.09 | 64 | Off |
| 24 Jul 2026 | 137.1 EUR | -1.2% | 140.2 EUR | 185.3 EUR | 0.98 | -24.51 | 63 | Off |
| 17 Jul 2026 | 138.9 EUR | 4.3% | 141.1 EUR | 186.0 EUR | 0.90 | -23.13 | 121 | Off |
| 10 Jul 2026 | 133.1 EUR | -3.3% | 142.0 EUR | 186.5 EUR | 0.52 | -28.27 | 189 | Off |
| 3 Jul 2026 | 137.6 EUR | 0.6% | 143.2 EUR | 187.1 EUR | 0.14 | -27.32 | 0 | Off |
| 26 Jun 2026 | 136.9 EUR | 9.1% | 144.1 EUR | 187.6 EUR | -0.17 | -26.57 | 0 | Off |
| 19 Jun 2026 | 125.4 EUR | -0.3% | 145.0 EUR | 188.2 EUR | -0.66 | -34.44 | 0 | Off |
| 12 Jun 2026 | 125.8 EUR | -4.1% | 146.4 EUR | 188.8 EUR | -0.91 | -32.03 | 0 | Off |
| 5 Jun 2026 | 131.2 EUR | 4.1% | 147.6 EUR | 189.4 EUR | -0.95 | -27.74 | 0 | Off |
| 29 May 2026 | 126.0 EUR | 0.8% | 148.3 EUR | 190.0 EUR | -1.06 | -31.80 | 0 | Off |
| 22 May 2026 | 125.0 EUR | 2.4% | 149.2 EUR | 190.6 EUR | -1.06 | -31.06 | 0 | Off |
| 15 May 2026 | 122.1 EUR | -2.4% | 150.3 EUR | 191.2 EUR | -1.06 | -31.78 | 3 | Off |
| 8 May 2026 | 125.1 EUR | 0.1% | 151.5 EUR | 191.8 EUR | -1.17 | -30.95 | 33 | Off |
How to use this report
This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.